Antengene Presents Results From Two Late-Stage Clinical Studies Of Selinexor At ASH 2024
Antengene Presents Results From Two Late-Stage Clinical Studies Of Selinexor At ASH 2024 . (MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 SHANGHAI and HONG KONG, Dec. 9, 2024 /PRNewswire/ -- Antengene Corporation Limited (  "Antengene"  , SEHK: 6996), a leading innovative, commercial-stage ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108973905/Antengene-Presents-Results-From-Two-Late-Stage-Clinical-Studies-Of-Selinexor-At-ASH-2024
2024-12-09
rss
(MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 SHANGHAI and HONG KONG, Dec. 9, 2024 /PRNewswire/ -- Antengene Corporation Limited (  "Antengene"  , SEHK: 6996), a leading innovative, commercial-stage ...
Antengene Presents Results From Two Late-Stage Clinical Studies Of Selinexor At ASH 2024